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MicroRNAs are non-coding RNAs with roles in many cellular processes. Tissue-specific miRNA profiles associated with senescence have been described for several cell and tissue types. We aimed to characterise miRNAs involved in core, rather than tissue-specific, senescence pathways by assessment of common miRNA expression differences in two different cell types, with follow-up of predicted targets in human peripheral blood.

MicroRNAs were profiled in early and late passage primary lung and skin fibroblasts to identify commonly-deregulated miRNAs. Expression changes of their bioinformatically-predicted mRNA targets were then assessed in both cell types and in human peripheral blood from elderly participants in the InCHIANTI study. 

57/178 and 26/492 microRNAs were altered in late passage skin and lung cells respectively. 3 miRNAs (miR-92a, miR-15b and miR-125a-3p) were altered in both tissues. 14 mRNA targets of the common miRNAs were expressed in lung and skin fibroblasts, of which 2 demonstrated up-regulation in late passage skin and lung cells (LYST; p = 0.02 [skin] and 0.02 [lung] INMT; p = 0.03 [skin] and 0.04 [lung]). ZMPSTE24 and LHFPL2 demonstrated altered expression in late passage skin cells only (p = 0.01 and 0.05 respectively). LHFPL2 was also positively correlated with age in peripheral blood (p value = 6.6 X 10-5).












Aging is a complex process characterised by progressive deterioration in cellular, tissue and organismal function. As such, aging in man is associated with almost all common chronic diseases (). However, the decline in function is not uniform, with people aging at different rates. This heterogeneity of human aging and susceptibility to age-related disease are poorly understood and the molecular mechanisms that underlie these differences remain to be explained. 

A proportion of the heterogeneity could arise from inter-individual variability in the fine-tuning of gene expression. Studies in multiple tissues from several species have identified genes where transcript expression or mRNA processing are associated with aging  ADDIN EN.CITE (; ; ; ). Gene expression can be regulated at many points. At transcription, expression can be moderated by the presence within the cell of appropriate transcription factors, or by epigenetic changes such as DNA methylation or histone modifications which determine whether the heterochromatin is in an active state (). Secondly, primary mRNA transcripts can undergo alternative mRNA splicing, which enables one gene to code for many proteins by moderating exon inclusion or exclusion (), Finally, post-transcriptional regulation of mRNA stability or translation potential by microRNAs, or by RNA binding proteins can occur ().

MicroRNAs (miRNAs) are short non-coding RNAs around 22 nucleotides in length and represent crucial players in many physiological processes, including development, proliferation and many disease phenotypes (). MicroRNAs act on their mRNA targets by acting as guides to direct RNA-induced silencing complexes (RISC) to the target mRNA for degradation or translational repression (). Recognition of the target mRNA is through sequence complementarity of the mRNA to the ‘seed region’, the first 6-8 nucleotides of the microRNA. This complementarity allows binding to 3’ regions of the target mRNA transcripts and repressing their translation or targeting for degradation (). There are currently over 1800 identified mature human microRNA sequences () and each microRNA can target hundreds of mRNAs (); many transcripts have multiple microRNA binding sites in their 3’ untranslated region, which may act antagonistically or be complementary to one another. MicroRNAs regulate the expression of genes in most pathways and biological processes () and have the potential to regulate complex networks such as those found during cellular aging (). 





miRNA and mRNA extraction and Reverse Transcription from early and late passage skin and lung fibroblasts.
Tissue culture methods and protocols for in vitro cell senescence in skin fibroblasts and lung MRC5 fibroblasts have been previously described in () and  ADDIN EN.CITE () respectively. 

MicroRNAs were extracted from ‘early’ (passage = 7, population doublings = 23) and ‘late’ passage skin fibroblasts (passage = 18, population doublings = 45) using the ‘mirVanaTM miRNA Isolation Kit’ (Life Technologies, Foster City, USA) following the manufacturer’s instructions. Cellular senescence was confirmed by -galactosidase staining with molecular assessment of senescence as previously described (). Total RNA (350ng) extracted using the mirVana system was reverse transcribed in 7.5μl reactions using the Megaplex™ RT Primers, Human pool A v2.1 and the TaqMan® MicroRNA reverse Transcription Kit (Life Technologies, Foster City, USA). Cycling conditions for the reverse transcription of the ABI 7900HT platform (Life Technologies, Foster City, USA) were 40 cycles 16C for 2 minutes, 42C for 1 minute and 50C for 1 second followed by 85C for 5 minutes. 

MRC-5 human embryonic lung fibroblasts (obtained from ECACC) were grown in Dulbecco's Modified Eagle's Medium (Sigma, UK) supplemented with 10% fetal calf serum, 2 mM L-glutamine, 1× penicillin/streptomycin (Sigma, UK). Fibroblasts were grown in a humidified atmosphere of 5% CO2 and 95% air at ambient oxygen partial pressure at 37oC on 75 cm2 flasks (Corning Incorporated, USA), in 15 ml of medium. Cells were split at 90% confluence into identical fresh medium. Cells were harvested by washing twice in phosphate buffered saline (PBS; Sigma, UK). MicroRNAs were extracted from ‘early’ passage (population doublings = 28.8) and ‘late’ passage MRC5 fibroblasts (population doublings = 43.6) using the ‘mirVanaTM miRNA Isolation Kit’ (Life Technologies, Foster City, USA) following the manufacturer’s instructions. Total RNA extraction was carried out using the RNeasy kit (Qiagen) and cDNA synthesis was carried out using Superscript Vilo cDNA kit (Life Technologies) according to manufacturer’s instructions.

MicroRNA expression profiling from ‘Early’ and ‘Late’ passage skin fibroblasts

Quantitative RT-PCR reactions for human skin fibroblast miRNAs were performed on the ABI 7900HT platform using TaqMan® Array Human MicroRNA A Cards v2.0 (Life Technologies, Foster City, USA) containing 384 TaqMan® MicroRNA Assays. Reaction mix contained 6 μl of Megaplex™ RT product, 450 μl TaqMan® 2X Universal PCR Master Mix, No AmpErase® UNG and 444 μl nuclease-free water. 100 μl was dispensed in 8 chambers of each TLDA card and centrifuged twice for 1 minute at 1000rpm and sealed. Cycling conditions for the TLDA qRT-PCR reaction were 50C for 2 minutes, 94.5C for 10 minutes and 40 cycles of 97C for 30 seconds and 57.9C for 1 minute. Comparative Ct values were calculated to determine the expression of each microRNA transcript ().  Assessment of expression used a global normalisation strategy (), following removal of outliers with crossing points of <10 and > 38. Statistical analyses were carried out using STATA v16.0 (StataCorp LP, Texas, USA). T-test analysis was used to test any statistical significance of microRNA expression between the early and late passage cells. Data were Benjamini-Hochberg corrected to account for multiple testing, based on 178 miRNAs expressed in this tissue, with  set at q = 0.05.

MicroRNA and mRNA expression profiling in early and late passage lung Fibroblasts

MicroRNAs in primary lung fibroblasts were profiled by array technology using the ThermoScientific miRNA profiling system in early (proliferating) and late passage (senescent) cells. Relative Intensity data was subjected to statistical filtering, retaining miRNA probes with P-value <= 0.01. This resulted in 492 miRNA probes passing statistical filters. Data was inter-array scaled and transformed to log2. This annotated, filtered, scaled and log2-transformed data set was used for subsequent analysis. Differential expression between samples was calculated using empirical Bayes statistics on the normalised expression data after the data was fitted to a linear model using the LIMMA  Bioconductor package ().

Differential mRNA expression on human lung fibroblasts was undertaken using an Agilent whole genome human 4X44K Gene expression array.  The relative intensity data was normalised using the RMA algorithm (Robust Microarray Average) using the Bioconductor package Affy ().  The normalised data was then fitted to a linear model using the LIMMA package (Smyth, 2004) and changes in gene expression calculated using empirical Bayes statistics.

Human peripheral blood transcriptional analysis 

We analysed microarray data from participants at the 9-year follow-up of the InCHIANTI study, which has been previously described  ADDIN EN.CITE (; ; ; ). 695 subjects aged between 30 and 104 years old with a mean age of 72.3 years (standard deviation 15.3 years). Full characteristics of the population used in this study are given in Harries et al. 2011). Whole transcriptome profiles were generated from using Illumina HT-12 microarray technology (Illumina, San Diego, California, USA) (). Array data can be accessed in the Gene Expression Omnibus database under accession number GSE48152. The InCHIANTI population is a well characterised, large cross sectional population study which has been extensively used for the study of human aging traits  ADDIN EN.CITE (). Ethical approval was granted by the Instituto Nazionale Riposo e Cura Anziani institutional review board.

Identification of target genes of the most senescence-associated microRNAs
We used the miRNA target predictor web interface MirWalk (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/ (​http:​/​​/​www.umm.uni-heidelberg.de​/​apps​/​zmf​/​mirwalk​/​​)) to identify putative targets of the 3 microRNAs demonstrating significantly altered expression in a consistent direction in early and late passage lung and skin fibroblasts (). We searched within the 3’ UTR binding sites for minimum seed length of 7 for the longest transcripts of the human genes, in 5 comparative prediction programs (miRanda, miRDB, miRWalk, RNA22 and Targetscan) (). 

Assessment of expression status of bioinformatically-predicted target genes in skin and lung fibroblasts. 

RNA from early and late passage primary lung and skin fibroblasts were used for demonstrating expression changes in predicted target genes to the three common miRNAs showing common expression differences in both fibroblast types, using qRT-PCR. SYBR green qPCR amplification was performed using SensiFASTTM SYBR® No-ROX Kit (Bioline, UK). qPCR reactions were carried out in a total reaction volume of 20μL, containing 2x SensiFASTTM SYBR® No-ROX Mix, 8μM each of forward and reverse primers and 1μL template cDNA. Reactions were carried out using a Rotor-Gene 3000 system (Qiagen, Germany) using following parameters: polymerase activation for 2 minutes at 95 °C, and 40 cycles of denaturation for 5s at 95°C, annealing for 10s at 60°C and extension for 20s at 72°C. A melt curve was carried out from 55°C to 95°C to determine product purity. Rotor-Gene 6000 series 1.7 software was used for analysing and quantifying the data. A threshold value of 0.03097 was used for determination of all Ct values. qRT-PCRs were performed in technical duplicates or triplicates and biological triplicates. Results of the technical duplicates were averaged. Ct-values of our genes of interest were normalised using Ct-values of GAPDH. Error-bars were calculated from the standard deviation of the biological triplicates of these normalized Ct-values. The rules for propagation of uncertainty were followed to calculate the standard deviations on the final fold change values. The normalized Ct-values were averaged, after which the log2fold-change and the fold change were calculated using the Livak method.

Assessment of expression status of bioinformatically-predicted target genes in human peripheral blood from an aging population.

We also assessed the relationship between gene expression and age for the 19 genes predicted to be targets of the 2 common miRNAs in microarray data from peripheral blood samples from an aging population (the InCHIANTI study) by multivariate linear regression analysis. Regression analysis was carried out using the R statistical package v3 (New Jersey, USA). Models were adjusted for confounding factors including batch effects, sex, waist circumference (continuous trait), smoking status in lifetime pack years smoked (in four categories: none, <20yrs, 20-39 years, 40+ yrs) education level in five categories (none, elementary, secondary, high school, and university), study site and white cell subtype count (neutrophil, lymphocyte, monocyte and eosinophil percentages).

Cubic Spline analysis to assess linearity of association






57 miRNAs are associated with replicative senescence in primary human skin fibroblasts

We assessed the profile of microRNA expression in early and late passage primary skin fibroblasts. 178 out of 380 microRNAs tested were expressed in early or late passage fibroblasts. Of these, 57 were significantly associated with senescence following Benjamini Hochberg adjustment for multiple testing. All microRNA transcripts had lower expression in late passage fibroblasts except hsa-miR-138, which had 3 fold higher expression in the late passage skin fibroblasts (Table 1). Among the most down-regulated microRNAs in senescence include miR-27b, miR-455, miR-337-5p, miR-135b and miR-579, (p = 7.6x10-8, 1.4x10-7, 2.0x10-7, 2.4x10-7 and 2.0x10-6 respectively).

26 miRNAs are associated with replicative senescence in primary human lung fibroblasts

We assessed the profile of microRNAs expressions in early and late passage primary lung fibroblasts. 492 microRNAs tested were expressed in primary lung fibroblasts. 26 of these were significantly associated with cellular senescence following empirical Bayes testing (table 2). 8 miRNAs were down-regulated and 18 were up-regulated.  The most down-regulated miRNAs in primary lung fibroblasts were hsa-miR-155 and hsa-miR-484 both of which showed a drop in expression by almost half. In contrast hsa-miR-127-3p (p = 5.1x10-4) and hsa-miR-768-3p (p = 4.2x10-4) showed the greatest level up-regulation with both more than doubling their expression during senescence.

Senescent cells of different lineages demonstrate tissue-specificity in miRNA profiles

380 miRNAs were tested by qRTPCR in skin fibroblasts and 703 miRNAs were tested by microarray in the lung fibroblasts. 365 miRNAs were common to both arrays. 178/380 miRNAs were expressed in skin fibroblasts and 492/703 miRNAs were expressed in lung fibroblasts. 174 miRNAs were present and expressed in both lung and skin cells. Despite this considerable overlap, only 3 of 174 (1.7%) commonly expressed miRNAs were associated with cellular senescence in both tissue types. The majority of miRNAs therefore demonstrated tissue-specificity in their expression in response to cellular senescence, with only 3 miRNAs, miR-92a, miR-125a-3p and miR-15b demonstrating consistent effects with senescence in both tissue types (tables 1 and 2).

miRNAs demonstrating similar expression differences in early and late passage lung and skin fibroblasts are predicted to target 19 mRNAs

We employed bioinformatics to identify putative targets of the 3 microRNAs associated with replicative senescence in both skin and lung fibroblasts. The 3 microRNAs in question, miR-92a and miR-15b, were predicted to regulate 19 mRNAs as determined by MirWalk prediction (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/). Of these 19 genes, 14 were expressed in both skin and lung fibroblasts when assessed by qRTPCR. 2 mRNA targets, LYST and INMT, showed expression differences in lung fibroblasts and 4 in skin fibroblasts (table 3; figure 1). The lysosomal trafficking regulator (LYST) gene, predicted to be targeted by miR-92a demonstrates 4.4X and 2.5X higher expression in late passage lung and skin fibroblasts respectively (p = 0.02 and 0.02), whereas the indolethylamine N-methyltransferase (INMT) gene, predicted to be regulated by miR-125a-3p, demonstrates 3.3X and 4.3X higher expression in late passage lung and skin cells respectively p = 0.02 and 0.03). The lipoma HMGIC fusion partner-like 2 (LHFPL2) gene predicted to be regulated by miR-92a, and the zinc metallopeptidase STE24 (ZMPSTE24) gene, predicted to be targeted by miR-125a-3p, both demonstrate elevated expression in late passage skin fibroblasts only (1.8X higher expression; p = 0.05 and 1.6X higher expression; p = 0.01 for LHFPL2 and ZMPSTE24 respectively).

Some miRNA target transcripts also demonstrate age-associated expression differences in peripheral blood.





We have identified senescence-associated changes in the mRNA milieu in early and late passage primary cells of two lineages; skin fibroblasts and lung fibroblasts. 57 miRNAs demonstrated altered expression in late passage skin fibroblasts, and 20 miRNAs demonstrated differential expression in late passage lung fibroblasts. Senescence-associated miRNA profiles demonstrated considerable tissue specificity, but 3 miRNAs, miR-92a and miR-15b showed similar differences in both datasets. MicroRNAs associated with senescence in multiple cell and tissue types may represent those more involved in regulation of ‘core’ aging processes that occur in multiple cell types, rather than representing more tissue-specific aspects of senescence. 

There has been accumulating evidence implicating microRNA regulation of aging genes in model organisms (; ). MicroRNA studies in humans have indicated that the majority of microRNAs decrease in abundance with age (), and our data are concordant with these observations in human skin fibroblasts, although the lung fibroblasts show more variability in this respect. In particular, miR-17, miR-19b, miR-20a and miR-106a demonstrate reduced expression with senescence in late passage skin fibroblasts, and have previously reported to demonstrate reduced expression in 4 additional aging models, including another study of skin fibroblasts and 3 in vivo animal models (). 

Elderly organisms have been described to display several ‘hallmarks’ of aging, including genome damage, telomere attrition, deregulated nutrient sensing, altered epigenetics, disrupted proteostasis, mitochondrial dysfunction, cellular senescence, stem cell exhaustion and altered intercellular communication ().  Accordingly, several of the miRNAs demonstrating expression differences in early and late passage primary skin fibroblasts and primary lung fibroblasts have been reported to regulate genes involved in these pathways. Several members of the Let-7 family were found to be down-regulated in late passage skin fibroblasts; this miRNA family has been reported to be involved in cellular senescence and stem cell exhaustion, by virtue of their regulation of the HGMA2 and CDKN2A transcripts (). Similarly, reduced expression of miR-24, present at reduced levels in late passage skin fibroblasts in our study, has previously been demonstrated to result in an increased expression of CDKN2A, which encodes p16ink4A and ARF, key markers of senescence in vivo and in vitro (). Components of the telomere maintenance machinery are also known to be targeted by miR-138 and miR-155. The TRF1 transcript, which encodes the telomeric repeat binding factor 1A, a critical component of the telomere assembly apparatus, is targeted by miR-155, which shows altered expression in late passage primary lung fibroblasts. Telomerase itself is regulated by miR-138, present at reduced levels in late passage primary skin fibroblasts. Components of the nutrient sensing and proteostasic pathways are also targeted by miRNAs showing altered expression in late passage skin fibroblasts; the PTEN gene, a key regulator of IGF1 and mTOR signalling is targeted by miR-19b, miR-17 miR-106a and miR-20a ().

The three miRNAs displaying consistent expression differences in late passage lung and skin cells, miR-92a and miR-15b were predicted by bioinformatics to target 19 mRNA transcripts. Of these, the LYST and INMT were present at elevated levels in both cell types. The LYST gene encodes the lysosomal trafficking regulator protein, which regulates movement of proteins within lysosomes. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder characterised by pigmentation changes, susceptibility to infection and bleeding abnormalities. It is fatal in its accelerated stages (). Mice with mutated LYST genes are prone to fibrosis during aging () and Rab-LYST trafficking was also found to be altered in a mouse model of Alzheimer’s Disease  ADDIN EN.CITE (). Dysregulated autophagy, a key marker of aging, is also a known outcome of lysosomal storage disorders (). 

The three miRNAs displaying consistent expression differences in senescent lung and skin cells, miR-92a, miR-125a-3p and miR-15b were predicted by bioinformatics to target 19 mRNA transcripts. Of these, the LYST and INMT were present at elevated levels in both cell types. The LYST gene encodes the lysosomal trafficking regulator protein, which regulates movement of proteins within lysosomes. Mutations in this gene are associated with Chediak-Higashi syndrome, a lysosomal storage disorder characterised by pigmentation changes, susceptibility to infection and bleeding abnormalities. It is fatal in its accelerated stages (). Mice with mutated LYST genes are prone to fibrosis during aging () and Rab-LYST trafficking was also found to be altered in a mouse model of Alzheimer’s Disease  ADDIN EN.CITE (). Dysregulated autophagy, a key marker of aging, is also a known outcome of lysosomal storage disorders (). The INMT gene, encodes the indolethylamine N-methyltransferase protein which is involved in xenobiotic metabolism. Age-related changes to the expression of this gene could potentially alter the activation or deactivation of carcinogens and therapeutic drugs in the elderly. 2 genes, the HMGIC fusion partner-like 2 (LHFPL2) gene and the zinc metallopeptidase STE24 (ZMPSTE24) gene demonstrated elevated expression only in senescent skin fibroblasts. LHFPL2 encodes a tetraspan transmembrane protein, mutations in which result in deafness in mice  ADDIN EN.CITE (). LHFPL2 was also found to be linked to differentiation of embryonic stem cells  ADDIN EN.CITE (), and so could have a role in stem cell exhaustion. The ZMPSTE24 or FACE1 gene encodes a metallopeptidase protein involved in the post-translational cleavage of Prelamin A to mature Lamin A. Lamin A is an important aging gene, which moderates the nuclear lamina to allow expression of multiple genes. Mutations at this locus cause Hutchinson-Gifford Progeria Syndrome (HGPS), an accelerated aging syndrome (). Mutations at ZMPSTE24 have also been reported in HGPS  ADDIN EN.CITE (). 

Three out of four of the mRNA targets of miRNAs deregulated by senescence in skin or lung fibroblasts were also associated with advancing age in peripheral blood from a cross-sectional population study of the aging, the InCHIANTI study.  Of these 3 genes, only LHFPL2 was shown to demonstrate a common direction of effect. Differences in direction of effect between in vitro and in vivo aging studies are not uncommon; indeed we have noted this phenomenon in previous studies  ADDIN EN.CITE (; ). There are several potential explanations for this phenomenon. Firstly, comparisons of a single homogeneous tissue such as a cell line with a mixed heterogeneous tissue such as blood can sometimes produce discrepant results. Blood is a complex mixture of different cell types and changes in gene expression can sometimes arise because of changes in the composition of the blood cell pool. Secondly, population studies can be subject to other internal and external environmental factors that may affect the expression of genes. Individuals within the population may have been exposed to confounding factors that the cells have not been exposed to. Finally, in living populations, expression changes with detrimental systemic outcomes may not be represented in our elderly samples because of survivor effects. 

The strengths of this study are the use of two different primary cell types within an in vitro model of human aging, with both miRNA and mRNA available from the same cells. This model enables the changes we are seeing do not represent a manifestation of other cell types or environmental factors and are not subject to confounding factors as seen found in human in vivo studies, however the direction and causality are attributable only to this cell type. We noted that 3 out of 4 genes demonstrating expression differences in both skin and lung fibroblasts also demonstrated altered expression in peripheral blood from elderly humans in a cross-sectional population study. This may indicate that these genes may have more general importance in the aging process.  

A limitation to our study is that in our in vitro model, most cells are undergoing senescence, whereas this is probably not the case a rapidly dividing cell population which is replenished from the stem cell pool. However, senescent cells are certainly present in vivo;  in the aging tissues of primates there is a senescent cell accumulation in vivo of more than 15% senescent cells, and this indicates in vitro senescence is a credible model of human aging (; ). It must also be noted that given the limitations of in-vitro models of senescence, which often do not employ large numbers of biological replicates, we may have identified only moderate to large effects, and other miRNA targets which show no expression differences in our study may prove to do so in larger, better powered studies of primary tissues. Another limitation lies in the use of different technologies to measure miRNA expression. Despite this, a significant number of miRNAs (365) were tested on both arrays. Of these, only 3/174 (1.7%) miRNAs that were expressed in both tissue types demonstrated associations with senescence, leading us to conclude that the small degree of overlap in senescence-associated miRNAs arises from tissue specificity rather than differences in the portfolio of miRNAs tested on the different platforms.  
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Table 2. MicroRNAs with differential regulation in senescent lung fibroblasts 
MicroRNA expression was assessed in ‘early’ and ‘late’ passage. The microRNA identity is given, along with the relative expression in the ‘early’ and ‘late’ passage lung fibroblasts, the p-values, and Benjamini Hochberg q-values (BH q-values) are given
	Relative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Table 3. Quantification of candidate mRNAs targeted by miRNAs associated with senescence in both skin and lung fibroblasts in senescent skin and lung fibroblasts. Mean expression values are given for each target gene in early passage (non-senescent) and late passage (senescent) lung and skin fibroblasts by qRT-PCR. RQ= Relative quantification. Figures in brackets are the standard deviation of measurement. Statistical significance assessed by t-test are given for each target. The miRNA predicted to target each transcript is given. The 5 genes not expressed in these cell types (CDH10, MAL2, SMYD4, TACC2, TPPP) have been omitted from the table.


































Table 4. Association between age and bioinformatically-predicted target gene expression in peripheral blood from a population study of aging.  We identified bioinformatically-predicted targets of MicroRNAs differentially expressed in both skin and lung fibroblasts and assessed potential associations with age in the InCHIANTI population study using fully adjusted multivariate linear regression.  N = number of individuals in the analysis and FDR = False discovery rate. Results are given below. Results falling below an FDR adjusted q-value of 0.05 were considered significant.  = beta coefficient, SE = standard error.








IVNS1ABP	hsa-miR-125a-3p	-0.0005	-0.0009 to 2.8 X 10-6	0.1
LHFPL2	hsa-miR-92a	0.0004	0.0002 to 0.0007	0.001
LYST	hsa-miR-92a	-0.0007	-0.001 to -0.0002	0.03
MAL2	hsa-miR-125a-3p	Not expressed		
SLC36A1	hsa-miR-15b	-0.0001	-0.0004 to 0.0002	0.4
SMYD4	hsa-miR-125a-3p	-0.0002	-0.0005 to 1.1X10-5	0.1
TACC2	hsa-miR-92a	Not expressed		
TCFL5	hsa-miR-92a	-0.0001	-0.0004 to 0.0002	0.4
TEX261	hsa-miR-125a-3p	0.0001	-6.8X10-5 to 0.0003	0.2
TPPP	hsa-miR-92a	Not expressed		
ZFP336L1	hsa-miR-125a-3p	-0.0002	-0.0004 to -1.6X10-6	0.09
ZMPSTE24	hsa-miR-125a-3p	-0.0012	-0.002 to -0.0004	0.02
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